Clinical Trials on Hormono-depending Adjuvant Breast Cancer in France

Total 1801 results

Centre Jean Perrin

Recruiting

Adapted Physical Activity for Breast Cancer HER2 Positive Patient (APACAN2)

HER2 Positive Breast Cancer

France
Centre Hospitalier Universitaire Dijon

Completed

Feasibility of Simulation in Therapeutic Patient Education for Adult Diabetic Patients Using the Freestyle Libre® Device (PRE-SIMPA)

Insulin-Dependent Diabetes

France
University Hospital, Grenoble

Recruiting

ACTIVPROSEIN : Professional Activity After Breast Cancer

Breast Cancer Female | Return to Work

France
Institut Cancerologie de l'Ouest
Telix Pharmaceutical; SIRIC ILIAD

Recruiting

Imaging Performance Assessment of 89Zirconium-labelled Girentuximab (89Zr-TLX250) PET-CT in Metastatic Triple Negative Breast Cancer Patients (OPALESCENCE)

Triple Negative Breast Cancer

France
Centre Jean Perrin

Recruiting

Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse in Triple Negative Breast Cancer Patients (INSTIGO)

Triple Negative Breast Cancer

France
Centre Antoine Lacassagne

Recruiting

Per-Operative Radiotherapy by Papillon +TM in Localized Breast Cancer (RPOS+2)

Localized Breast Cancer

France
Poitiers University Hospital

Recruiting

Interest of Circulating Tumor DNA in Digestive and Gynecologic/Breast Cancer

Breast Cancer | Gynecologic Cancer | Circulating Tumor DNA | Digestive Cancer | Exosomes

France
University of California, Irvine
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting

Breast Cancer | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | HER2-negative Breast Cancer

United States
Centre Antoine Lacassagne
Thuasne

Recruiting

Comparison of the Efficacy of Cryotherapy Combined With Compression in Preventing Neuropathy (ARIANE)

Non-metastatic Breast Cancer

France
Centre Antoine Lacassagne

Recruiting

Study to Determine the Safety and Efficacy of Ribociclib in Combination With Hormone Therapy and Hypofractionated Radiotherapy in Breast Cancer, With Positive Hormone Receptors and Negative HER2 Status, in Newly Diagnosed, Not Immediately Operable Elderly Patient (CALHYS) (CALHYS)

HER2 Negative Breast Cancer Not Immediately Operated

France
Institut de cancérologie Strasbourg Europe

Recruiting

Identification of Genetic Determinants for Treatment Resistance/Sensitivity and/or Toxicity in Adjuvant Setting for HER2 Positive Breast Cancer (SIGHER)

HER2-positive Breast Cancer

France
Institut Curie

Unknown

Medico-economic Interest of Taking Into Account Circulating Tumor Cells (CTC) to Determine the Kind of First Line Treatment for Metastatic, Hormone-receptors Positive, Breast Cancers

Ductal Infiltrating Metastatic Breast Cancer | Hormone-receptors Positive Breast Cancer

France
Centre Hospitalier Universitaire de Nīmes

Terminated

Satisfaction of Hospitalized Diabetic Patients Using a Continuous Glucose Monitoring System (GLUCO FLASH)

Insulin-Dependent Diabetes

France
Institut Curie

Not yet recruiting

Efficacy of Personalized Tumorogram-based Therapy in Cancer Established From Patient-derived Organoid (AVATAR)

Metastatic Breast Cancer

France
Institut Curie
Hoffmann-La Roche

Recruiting

Tiragolumab, Atezolizumab and Chemotherapy in Triple Negative Breast Cancer (SKYLINE)

Triple Negative Breast Cancer

France
Institut Curie
ProLynx LLC

Recruiting

A Study to Evaluate the Efficacy and Toxicities of PLX038, in Patients With Locally Advanced or Metastatic Triple-negative Breast Cancer (TOPOLOGY)

Cancer | Breast

France
Centre Francois Baclesse

Not yet recruiting

Use of a Virtual Reality Cognitive Stimulation Programme for Breast Cancer Patients Wishing to Restart or Maintain a Professional Activity (Cog-RV)

Breast Cancer | Cancer-related Cognitive Difficulties

France
Institut Paoli-Calmettes

Recruiting

Institut Paoli Calmettes Breast Cancer Database

Breast Cancer Diagnosis

France
Institut Cancerologie de l'Ouest

Active, not recruiting

Delayed Breast Reconstruction by Prepectoral Implant After Lipo-preparation (RM2prepec) (RM2prepec)

Breast Cancer Female

France
Centre Jean Perrin

Terminated

Phase II Pilot Study Assessing Efficacy of a Cisplatin - Métronomic Cyclophosphamide Treatment in Patients With Stade IV Triple Negative Breast Cancer Secondary Resistant to Anthracyclines and Taxanes (META2)

Metastatic Breast Cancer

France
Institut Paoli-Calmettes

Unknown

Triple Negative Breast Cancer: Study of Molecular and Genetic Factors

Breast Cancer

France
Institut Paoli-Calmettes

Recruiting

Database of Data Collection (BDD-G3S)

Surgery of Breast Cancer

France
Institut Cancerologie de l'Ouest

Completed

Biological Response to Tamoxifen (TAM) in Patients With Breast Cancer Non Metastatic RH+ (TAM)

Non Metastatic Breast Cancer

France
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Completed

S 81694 Plus Paclitaxel in Metastatic Breast Cancer

Metastatic Breast Cancer | Metastatic Triple Negative Breast Cancer

Japan, Belgium, France, Netherlands
Institut Curie
seintinelles network

Unknown

FErtility, PrEgnancy, contRaceptIon After Breast Cancer in France (FEERIC)

Breast Cancer Female

France
Neovii Biotech

Terminated

Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer Progressing After Endocrine Treatment

Advanced Breast Cancer | Metastatic Breast Cancer

Spain, Austria, France, Germany, Italy
Centre Jean Perrin

Recruiting

Correlation Between TILs and Blood Cell Counts in Triple Negative Breast Cancer Patients (PERCEPTION)

Triple Negative Breast Cancer

France
Thuasne

Recruiting

Evaluation of Mobiderm Intimate Bra in the Management of Breast Edema Related to Breast Cancer Treatment (MOBIBRA)

Breast Cancer Surgery

France
UNICANCER
Ministry of Health, France

Active, not recruiting

Safety Study of Adding Everolimus to Adjuvant Hormone Therapy in Women With High Risk of Relapse, ER+ and HER2- Primary Breast Cancer, Free of Disease After Receiving at Least One Year of Adjuvant Hormone Therapy

Primary Non-metastatic Breast Cancer | Who Remain Disease-free

France
UNICANCER

Recruiting

Chronic Toxicities Related to Treatment in Patients With Localized Cancer (CANTO)

Breast Cancer Nos Metastatic Recurrent

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Randomized Phase II Study to Assess PD 0332991 in Breast Cancer (POP)

Untreated Operable Early Breast Cancer

France
Institut Curie

Active, not recruiting

Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR)

Triple Negative Breast Cancer | Pediatric Cancer | Metastatic Uveal Melanoma | Luminal B Breast Cancer

France
Assistance Publique - Hôpitaux de Paris

Unknown

Follow-up of Elderly Patients in Ambulatory Surgery (PAPA)

Breast Cancer | Surgery | Skin Cancer | Ambulatory

France
Centre Jean Perrin

Recruiting

Xenografts Development From Surgical Tumor Samples of Patients With Triple Negative or Luminal B Breast Cancer (XenoBreast)

Breast Cancer Female

France
R-Pharm

Completed

Phase I Combination w/ Epirubicin

Metastatic Breast Cancer

Italy, France
Centre Jean Perrin

Terminated

Support and Rehabilitation Protocol for Non Metastatic Breast Cancer Patients in Complete Remission After Chemotherapy

Non Metastatic Breast Cancer

France
Centre Hospitalier Régional Metz-Thionville
Central Hospital, Nancy, France; University of Lorraine

Completed

EMDR Psychotherapy for Anxious-depressive Symptoms in Breast Cancer Patient (PSYCANCER)

Breast Cancer Female

France
Centre Oscar Lambret
Sysmex America, Inc.

Unknown

IDENTIFICATION OF SENTINEL NODE(S) IN BREAST CANCER (SENTIMAG)

BREAST CANCER

France
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Active, not recruiting

A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)

Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast Cancer | Musculoskeletal Complications

United States
Groupe Hospitalier Mutualiste de Grenoble
TIMC-IMAG; AG2R La Mondiale; GEFLUC; Espoir Isère Cancer

Completed

Autohypnosis and Cancerology

Breast Cancer | Colorectal Cancer

France
Ramsay Générale de Santé
European Clinical Trial Experts Network

Recruiting

Comparison of Changes in the Quality of Life of Patients Operated on Breast Cancer at the Drôme Ardèche Breast Institute According to Access to Supportive Oncological Care (IDSein) (IDSein)

Breast Cancer Female

France
Assistance Publique - Hôpitaux de Paris
Institut Pasteur

Completed

Prolactin Receptor and Breast Diseases (Prolacsein)

Breast Cancer | Benign Breast Disease

France
Hospices Civils de Lyon

Recruiting

Immediate Breast Reconstruction's Increasing (IBRI)

Breast Cancer | Breast Reconstruction

France
Centre Antoine Lacassagne

Completed

Preoperative Localization of Infraclinical Breast Tumors: Isotopic Localization by iodine125 Seed Versus Standard Localization Using a Metal Wire (IodineBreast)

Breast Cancer

France
Institut Claudius Regaud
Ligue contre le cancer, France

Recruiting

Male breAsT cAncer preDisposition Factor (MATADOR)

Breast Cancer

France
Centre Leon Berard

Completed

Study of Impact of Routine "Clinical Cancer Department/Supportive Care Department" Consultation on the Prescription of an Additional Line of Chemotherapy

Metastatic Breast Cancer

France
Centre Francois Baclesse
Groupement Interrégional de Recherche Clinique et d'Innovation; NATSUCA laboratory

Recruiting

Evaluation of the Impact of Taking American Ginseng for 8 Weeks on Fatigue in Patients Treated for Localized Breast Cancer (QISEIN)

Breast Cancer | Fatigue

France
Institut Paoli-Calmettes
Laboratoire Management Sport Cancer EA 4670

Unknown

Feasibility Study of an Adapted and Supported Water Polo Program to Reduce Fatigue Related to Cancer and Improve Psychological and Social Recovery in Patients With Breast Cancer Remission (AQUA-POLO)

Breast Cancer | Cancer Related Fatigue

France
Eli Lilly and Company

Completed

A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer (monarcHER)

HER-2 Positive Breast Cancer | Hormone Receptor Positive Breast Cancer

Spain, United States, Korea, Republic of, Belgium, France, Germany, Italy, Australia, Argentina, Canada, United Kingdom, Mexico, Brazil, Greece
Institut Cancerologie de l'Ouest
SIRIC ILIAD

Completed

[18F]-DPA-714 PET/CT (Positron Emission Tomography/Computerized Tomography) in Triple Negative Breast Cancers (EITHICS)

Triple Negative Breast Cancer

France

Clinical Trials on Hormono-depending Adjuvant Breast Cancer in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations